SRSohaib R. Rufai

Sohaib R. Rufai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sohaib R. Rufai has a total of 110 co-authors. Here are the top co-authors by number of shared publications:

  • Catey Bunce

    Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK

    7 shared publications
  • Noor Ul Owase Jeelani

    Craniofacial Unit, Great Ormond Street Hospital for Children NHS Foundation Trust and UCL Great Ormond Street Institute of Child Health, London, UK

    7 shared publications
  • Mervyn G. Thomas

    The University of Leicester Ulverscroft Eye Unit, Leicester Royal Infirmary, Leicester, UK

    5 shared publications
  • Irene Gottlob

    The University of Leicester Ulverscroft Eye Unit, Leicester Royal Infirmary, Leicester, UK

    4 shared publications
  • Vasiliki Panteli

    Clinical and Academic Department of Ophthalmology, Great Ormond Street Hospital for Children NHS Foundation Trust and UCL Great Ormond Street Institute of Child Health, London, UK

    4 shared publications
  • Richard Bowman

    Clinical and Academic Department of Ophthalmology, Great Ormond Street Hospital for Children NHS Foundation Trust and UCL Great Ormond Street Institute of Child Health, London, UK

    3 shared publications

Latest Publications

  • Open Access

    Recognition of intracranial hypertension in children with craniosynostosis using handheld OCT: a diagnostic accuracy study

    by Sohaib R. Rufai, Ravi Purohit, Richard Bowman, Irene Gottlob, Catey Bunce, Vasiliki Panteli, Dorothy A. Thompson, Oliver R. Marmoy, Robert H. Henderson, Jody O’COnnor, et al.

    Craniosynostosis is often associated with intracranial hypertension (IH), which can damage the brain and vision if unaddressed. This prospective, multicentre diagnostic accuracy study evaluated the diagnostic accuracy of handheld optical coherence tomography (OCT) in recognising IH in craniosynostosis. Handheld OCT was performed in children with craniosynostosis at the time of gold-standard overnight intracranial pressure (ICP) monitoring. Mixed model regression assessed for associations with ICP. Qualitative OCT signs of IH were raised cup and rim, cup obliteration, anterior displacement of Bruch’s membrane and severe optic atrophy. Primary quantitative OCT measures were disc width, cup width, rim width, and retinal nerve fibre layer (RNFL) thickness (nasal/temporal). Of 37 eligible children, handheld OCT was successful in 36 (97%). Eighteen children (50%) were female. Eleven children (31%) had syndromic craniosynostosis. Median age at examination was 76 months (range 14–205 months; IQR 46–105 months). When defining IH as mean ICP ≥ 20 mmHg ± prolonged ICP spikes, qualitative OCT sensitivity was 89% (95% CI 65–99) and specificity was 63% (95% CI 38–84). Anterior displacement of Bruch’s membrane delivered 100% specificity for IH. Area under the ROC curve (AUC) was 0.78 (95% CI 0.67–0.89) for disc width, 0.81 (95% CI 0.71–0.91;) for rim width, and 0.74 (95% CI 0.62–0.86;) for nasal RNFL thickness; all three were significantly associated with IH ( P < 0.004, P < 0.001 and P = 0.014, respectively). In conclusion, handheld OCT can recognise IH in craniosynostosis, and could improve early intervention and clinical outcomes. ISRCTN registration ID: ISRCTN52858719.

  • Open Access

    Factors affecting outdoor time and screentime in the context of preschool myopia prevention: a mixed-methods study

    by Simran Khutan, Rebecca J. McLean, Mervyn G. Thomas, Sohaib R. Rufai

  • Open Access

    Feasibility and reproducibility of handheld and table-mounted optical coherence tomography in children with craniosynostosis

    by Sohaib R. Rufai, Dermot Roche, Riddhi Shenoy, Oliver R. Marmoy, Vasiliki Panteli, Dorothy A. Thomson, Robert H. Henderson, Irene Gottlob, Mervyn G. Thomas, Catey Bunce, et al.

    Background: Optical coherence tomography (OCT) can be a valuable tool for non-invasively monitoring the optic nerve status in children with craniosynostosis. However, it is currently unknown whether optic nerve parameters derived from handheld OCT are comparable to those derived from table-mounted OCT, which is more widely used. This study aims to assess the feasibility and reproducibility of handheld and table-mounted OCT in craniosynostosis. Methods: This was a cross-sectional study conducted at Great Ormond Street Hospital (GOSH), London. Twenty children aged 4–18 years with a clinical/genetic diagnosis of craniosynostosis were included. Bilateral optic nerve head OCT imaging was performed using the Spectralis (Heidelberg Engineering), followed by the handheld Envisu C2300 (Leica Microsystems). Primary outcome measures were quantitative cup, disc, rim and peripapillary parameters. Intraclass correlation coefficients (ICC) and coefficient of variation (CoV) were calculated for each quantitative OCT parameter. Results: 20 children (100%) were successfully recruited. Median age at the time of OCT examination was 6 years (range: 4–16; IQR: 5–8). Ten participants (50%) were female. Seven participants (35%) had syndromic craniosynostosis and 13 participants (65%) had non-syndromic craniosynostosis. Bilateral imaging success was 100% for both machines. ICCs were good-to-excellent for all parameters, ranging from 0.81 to 1.00. The coefficient of variation was low for all parameters. Conclusions: OCT imaging of the optic nerve is feasible in school-aged children with craniosynostosis and comparable between the Spectralis and handheld Envisu OCT. This could allow comparison and pooling of data between the two machines, greatly enhancing patient care and future research.

  • Open Access

    Optic Nerve Head Morphological Variation in Craniosynostosis: A Cohort Study

    by Sohaib R. Rufai, Mervyn G. Thomas, Oliver R. Marmoy, Vasiliki Panteli, Dorothy A. Thompson, Catey Bunce, Robert H. Henderson, Sri Gore, Greg James, Irene Gottlob, et al.


  • Open Access

    Home-based screening tools for amblyopia: a systematic review

    by Samantha Siaw Zhen Sii, Chung Shen Chean, Helen Kuht, Catey Bunce, Mervyn G. Thomas, Sohaib R. Rufai

    Amblyopia is an important public health concern. While home-based screening may present an effective solution, this has not been rigorously assessed in a systematic review. A systematic review was performed using Ovid MEDLINE, PubMed, The Cochrane Library, Embase, Web of Science Core Collection, and Clinicaltrials.gov. All studies reporting the diagnostic accuracy of home-based screening tools for amblyopia among children were included. Studies involving orthoptist or ophthalmologist-led screening and adult subjects were excluded. The main outcome measure was the diagnostic accuracy expressed as sensitivity and specificity. Among 3670 studies identified, 28 were eligible for inclusion in our systematic review. The age range of patients were less than 1 month to 16 years old. 7 studies used internet-based tools, 16 used smartphone/tablet applications, 3 used digital cameras, and 3 used home-based questionnaires and visual acuity tools. All studies included a reference standard except one, which was a longitudinal study. 21 studies had full ophthalmological examination whilst 6 studies had validated visual acuity measurement tools as gold standards. Of the 27 studies which compared against a reference test, only 25 studies reported sensitivity and specificity values. Using the QUADAS-2 tool, 50% of studies were deemed to have applicability concern due to patient selection from tertiary centres and unclear methods for recruitment. There is a need to improve the quality of diagnostic accuracy studies, standardise thresholds for detecting amblyopia, and ensure consistent reporting of results. Further research is needed to evaluate the suitability of these tools for amblyopia screening.


  • Open Access

    Feasibility of a portable optical coherence tomography system in children with craniosynostosis

    by Ravi Purohit, Sohaib R. Rufai, Chetan Khantibai Patel, Gregory P. L. Thomas, Noor Ul Owase Jeelani, David Johnson, Tim P. Lawrence


  • Anterior displacement of Bruch’s membrane: a useful sign for intracranial hypertension in craniosynostosis

    by S. R. Rufai, J. D. Blum, C. Kalmar, R. Avery, N. U. O. Jeelani, F. A. Proudlock, J. W. Swanson


  • Open Access

    Recognition of intracranial hypertension using handheld optical coherence tomography in children (RIO Study): a diagnostic accuracy study protocol

    by Sohaib R Rufai, Noor Ul Owase Jeelani, Richard Bowman, Catey Bunce, Frank A Proudlock, Irene Gottlob

    Introduction Paediatric intracranial hypertension (IH) is a rare but serious condition that can pose deleterious effects on the brain and vision. Estimating intracranial pressure (ICP) in children is difficult. Gold standard direct ICP measurement is invasive and carries risk. It is impractical to routinely perform direct ICP measurements over time for all children at risk of IH. This study proposes to assess the diagnostic accuracy of handheld optical coherence tomography (OCT), a non-invasive ocular imaging method, to detect IH in children. Methods and analysis This is a prospective study evaluating the diagnostic accuracy of handheld OCT for IH in at risk children. Inclusion criteria include clinical and/or genetic diagnosis of craniosynostosis, idiopathic intracranial hypertension, space occupying lesion or other conditions association with IH and age 0–18 years old. Exclusion criteria include patients older than 18 years of age and/or absence of condition placing the child at risk of IH. The primary outcome measures are handheld OCT and 48-hour ICP assessments, which will be used for diagnostic accuracy testing (sensitivity, specificity, positive predictive value, negative predictive value and accuracy). Main secondary outcome measures include visual acuity, fundoscopic examination, contrast sensitivity, visual field testing and visual evoked potentials, wherever possible. Ethics and dissemination Ethical approval was granted for this study by the East Midlands Nottingham 2 Research Ethics committee (UOL0348/IRAS 105137). Our findings will be disseminated through presentation at relevant meetings, peer-reviewed publication and via the popular media. Trial registration number ISRCTN52858719


  • Open Access

    Home-based screening tools for amblyopia: a systematic review protocol

    by Samantha Sii, Chung Shen Chean, Helen J Kuht, Mervyn G Thomas, Sohaib R Rufai

    Introduction Amblyopia is an important public health concern associated with functional vision loss and detrimental impact on the physical and mental well-being of children. The gold standard for diagnosis of amblyogenic conditions currently involves screening by orthoptists and/or ophthalmologists. The bloom of technology enables the use of home-based screening tools to detect these conditions at an early stage by the layperson in community, which could reduce the burden of screening in the community, especially during restrictions associated with the COVID-19 pandemic. Here, we propose a systematic review aiming to evaluate the accuracy and reliability of home-based screening tools compared with the existing gold standard. Methods and analysis We aim to search for studies involving home-based screening tools for amblyopia among children aged under 18 years. Oxford Centre for Evidence-Based Medicine Level 4 evidence and above will be included, without language or time restrictions. The following platforms will be searched from inception to 31 August 2021: PubMed, Medline, The Cochrane Library, Embase, Web of Science Core Collection and Clinicaltrials.gov. Two independent reviewers will identify studies for inclusion based on a screening questionnaire. The search and screening will start on 14 August 2021 until 1 October 2021. We aim to complete our data analysis by 30 November 2021. Risk of bias will be assessed using the Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool for diagnostic accuracy studies only. Our primary outcome measure is the diagnostic accuracy of home-based screening tools, while secondary outcome measures include validity, feasibility, reproducibility and cost-effectiveness, where available. Ethics and dissemination Ethical approval is not necessary as no primary data will be collected. The findings will be disseminated through presentations at scientific meetings and peer-reviewed journal publication. PROSPERO registration number CRD42021233511.